Risk factors: CVD risk and the 'Obesity Paradox'

Nature Reviews Cardiology

Volumn 12, Issue 10, 2015, Pages 560-

  Lim, Gregory B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; CARDIOVASCULAR AGENT;

ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; FOLLOW UP; HUMAN; INVESTIGATIVE PROCEDURES; NOTE; OBESITY; OUTCOME ASSESSMENT; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK FACTOR; SECONDARY PREVENTION; UNDERWEIGHT; CARDIOVASCULAR DISEASES; FEMALE; MALE;

CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE;

EID: 84941877729     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2015.128     Document Type: Note

References (1)

1. Hansel B., et al. Cardiovascular risk in relation to body mass index and use of evidence-based preventive medications in patients with or at risk of atherothrombosis. Eur. Heart J. doi: 10.1093/eurheartj/ehv347